Diseases & Illness |

Stroke News

Evista Associated with Stroke Risk

RSS News Feeds
Disease from Products
Stroke
 All RSS Feeds

At a glance:

A new concern has surfaced for the osteoporosis medication Raloxifene (Evista). 
 
Post menopausal women with known heart disease or at high risk for heart disease were studied and those taking Evista had a higher risk for death from stroke than those on a placebo. 
 
Evista may still be indicated for women who do not have heart disease, but this result should be taken into account when balancing the risks and rewards of this medication. 
 

Evista associated with increased risk of stroke mortality in ...

Xagena.it - 6/3/2006 11:35 AM

Health Canada has informed Health Care Professionals of important new safety information regarding Evista ( Raloxifene ) resulting from the Raloxifene Use for The Heart ( RUTH ) trial.
 
The RUTH trial, a large-scale placebo-controlled study, investigated whether a 60 mg daily dose of Raloxifene would reduce the risk of coronary events and the risk of invasive breast cancer in postmenopausal women with known heart disease or at high risk for a coronary event.
 
· Read The Full Stroke Article From Xagena.it -->

· Read All Stroke News Stories -->

Comments On Stroke News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: